Cited by 8Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

“Exceptions that prove the rule”–Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia‐Alzheimer's disease syndrome?

Open access

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.12633

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • As suggested in Breitner et al. (2022), behavioral interventions that affect symptomatic features to a significant extent are as important as pharmacological interventions targeting pathological changes, and may shed light on disease mechanisms affecting neural plasticity.

    “As suggested in a recent editorial (Breitner et al., 2022), behavioral interventions that affect symptomatic features to a significant extent (even without modifying pathology) are as important as pharmacological interventions targeting pathological changes, and may shed light on disease mechanisms affecting neural plasticity.”

    From Internet-Based Conversational Engagement Randomized Controlled Clinical Trial (I-CONECT) Among Socially Isolated Adults 75+ Years Old With Normal Cognition or Mild Cognitive Impairment: Topline Results (2024) · cites this paper as Breitner et al., 2022

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 22

  1. 10.1002/trc2.12202 · DOI
  2. 10.1002/alz.12393 · DOI
  3. 10.1007/978-0-387-75688-2 · DOI
  4. 2022, Principles of Epidemiology in Public Health Practice
  5. 10.1212/01.wnl.0000271090.28148.24 · DOI · Paper page
  6. 10.1016/j.trci.2016.09.002 · DOI
  7. 10.1093/brain/awt188 · DOI · Paper page
  8. 10.1016/j.jalz.2016.11.003 · DOI
  9. 10.1016/S1474-4422(15)70016-5 · DOI · Paper page
  10. 10.3233/JAD-170887 · DOI
  11. 10.1212/WNL.42.9.1681 · DOI · Paper page
  12. 10.1097/01.psy.0000250264.25017.21 · DOI
  13. 10.1016/j.psyneuen.2004.04.005 · DOI
  14. 10.1212/WNL.38.11.1682 · DOI · Paper page
  15. 10.1001/archneur.65.11.1509 · DOI · Paper page
  16. 10.1017/S1041610213001749 · DOI
  17. 10.1016/j.jalz.2010.11.007 · DOI
  18. 10.1016/j.jalz.2016.12.006 · DOI · Paper page
  19. 10.1016/j.jalz.2015.10.002 · DOI
  20. 10.1016/j.jalz.2019.05.007 · DOI
  21. 10.1016/j.jalz.2016.04.008 · DOI
  22. 10.1016/j.jalz.2016.05.005 · DOI

Cited by

Sorted by citations

Metadata

Authors
Breitner, J. C. S., Dodge, H. H., Khachaturian, Z. S., & Khachaturian, A. S.
Affiliations
  • Douglas Mental Health University Institute (CA)
  • Oregon Health & Science University (US)
  • Alzheimer's Association (US)
Corresponding author
Khachaturian, Ara S.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2022-03
Volume
18
Issue
3
Pages
389-392
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4221039044
Cited by
8
References
3
Citations by year
2025: 2 · 2024: 2 · 2023: 2 · 2022: 2
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (P30AG066518)
  • McGill University
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
Alzheimer's disease, dementia
MeSH terms
Alzheimer Disease, Humans, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review